Maraviroc
Hind Fadel, Zelalem Temesgen
pág. 749
Idursulfase in Hunter syndrome treatment
Grazyna Zareba
pág. 759
Levetiracetam
Mar Carreño Martínez
pág. 769
Tipifarnib in acute myeloid leukemia
Alan K. Burnett, J. Kell
pág. 795
Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (Update)
Baptist Gallwitz
pág. 801
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes
Chris R. Triggle
pág. 815
Drug-induced optic neuropathies
Michael J. Lloyd, Frederick W. Fraunfelder
pág. 827
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: